| Overview |
| bs-6807R-FITC |
| CTAG2 Polyclonal Antibody, FITC Conjugated |
| WB |
| Human |
| Specifications |
| FITC |
| Rabbit |
| KLH conjugated synthetic peptide derived from human CTAG2 |
| 121-210/210 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 30848 |
| O75638 |
| Cytoplasm |
| CT2; ESO2; CAMEL; CT6.2; CT6.2a; CT6.2b; LAGE-1; LAGE2B; Cancer/testis antigen 2; Autoimmunogenic cancer/testis antigen NY-ESO-2; Cancer/testis antigen 6.2; L antigen family member 1; CTAG2; LAGE1 |
| Testis and very low level in placenta and in some uterus samples. Observed in 25-50% of tumor samples of melanomas, non-small-cell lung carcinomas, bladder, prostate and head and neck cancers. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz